Filtros : "Lancet" "2022" Removido: "FM-MNE" Limpar

Filtros



Limitar por data


  • Fonte: Lancet. Unidade: FM

    Assuntos: COVID-19, MORTALIDADE, PANDEMIAS

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Haidong et al. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet, v. 399, n. 10334, p. 1513-1536, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(21)02796-3. Acesso em: 31 ago. 2024.
    • APA

      Wang, H., Paulson, K. R., Pease, S. A., Watson, S., Comfort, H., Zheng, P., et al. (2022). Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet, 399( 10334), 1513-1536. doi:10.1016/S0140-6736(21)02796-3
    • NLM

      Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, Aravkin AY, Bisignano C, Barber RM, Lotufo PA. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21 [Internet]. Lancet. 2022 ; 399( 10334): 1513-1536.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(21)02796-3
    • Vancouver

      Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, Aravkin AY, Bisignano C, Barber RM, Lotufo PA. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21 [Internet]. Lancet. 2022 ; 399( 10334): 1513-1536.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(21)02796-3
  • Fonte: Lancet. Unidade: FM

    Assuntos: CONSENSO, NEOPLASIAS, FATORES DE RISCO

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      KHANH BAO TRAN, et al. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, v. 400, n. 10352, p. 563-591, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)01438-6. Acesso em: 31 ago. 2024.
    • APA

      Khanh Bao Tran,, Lang, J. J., Compton, K., Xu, R., Acheson, A. R., Henrikson, H. J., et al. (2022). The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 400( 10352), 563-591. doi:10.1016/S0140-6736(22)01438-6
    • NLM

      Khanh Bao Tran, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, Kocarnik JM, Penberthy L, Aali A, Alonso N. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019 [Internet]. Lancet. 2022 ; 400( 10352): 563-591.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)01438-6
    • Vancouver

      Khanh Bao Tran, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, Kocarnik JM, Penberthy L, Aali A, Alonso N. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019 [Internet]. Lancet. 2022 ; 400( 10352): 563-591.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)01438-6
  • Fonte: Lancet. Unidade: FM

    Assuntos: COVID-19, FATORES DE RISCO, PAÍSES DESENVOLVIDOS, PAÍSES EM DESENVOLVIMENTO, PNEUMONIA

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOLLYKY, Thomas J et al. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. Lancet, v. 399, n. 10334, p. 1489-1512, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00172-6. Acesso em: 31 ago. 2024.
    • APA

      Bollyky, T. J., Hulland, E. N., Barber, R. M., Collins, J. K., Kiernan, S., Moses, M., et al. (2022). Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021. Lancet, 399( 10334), 1489-1512. doi:10.1016/S0140-6736(22)00172-6
    • NLM

      Bollyky TJ, Hulland EN, Barber RM, Collins JK, Kiernan S, Moses M, Pigott DM, Reiner Junior RC, Sorensen RJD, Lotufo PA. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 [Internet]. Lancet. 2022 ; 399( 10334): 1489-1512.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00172-6
    • Vancouver

      Bollyky TJ, Hulland EN, Barber RM, Collins JK, Kiernan S, Moses M, Pigott DM, Reiner Junior RC, Sorensen RJD, Lotufo PA. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 [Internet]. Lancet. 2022 ; 399( 10334): 1489-1512.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00172-6
  • Fonte: Lancet. Unidade: FM

    Assuntos: ESTUDOS DE COORTES, HIPERCOLESTEROLEMIA, CRIANÇAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TROMP, Tycho R. et al. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet, v. 399, n. 10326, p. 719-728, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50469. Acesso em: 31 ago. 2024.
    • APA

      Tromp, T. R., Hartgers, M. L., Hovingh, G. K., Vallejo-vaz, A. J., Ray, K. K., Soran, H., et al. (2022). Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet, 399( 10326), 719-728. doi:10.1016/S0140-6736(21)02001-8
    • NLM

      Tromp TR, Hartgers ML, Hovingh GK, Vallejo-vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-shiba M, Blom DJ. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study [Internet]. Lancet. 2022 ; 399( 10326): 719-728.[citado 2024 ago. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50469
    • Vancouver

      Tromp TR, Hartgers ML, Hovingh GK, Vallejo-vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-shiba M, Blom DJ. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study [Internet]. Lancet. 2022 ; 399( 10326): 719-728.[citado 2024 ago. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50469
  • Fonte: Lancet. Unidade: FM

    Assuntos: BEBIDAS ALCOÓLICAS, FATORES DE RISCO, DOENÇAS

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BRYAZKA, Dana et al. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet, v. 400, n. 10347, p. 185-235, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00847-9. Acesso em: 31 ago. 2024.
    • APA

      Bryazka, D., Reitsma, M. B., Griswold, M. G., Abate, K. H., Abbafati, C., Kangevari, M. A., et al. (2022). Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet, 400( 10347), 185-235. doi:10.1016/S0140-6736(22)00847-9
    • NLM

      Bryazka D, Reitsma MB, Griswold MG, Abate KH, Abbafati C, Kangevari MA, Kangevari ZA, Abdoli A, Benseñor IJM, Brunoni AR. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 [Internet]. Lancet. 2022 ; 400( 10347): 185-235.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00847-9
    • Vancouver

      Bryazka D, Reitsma MB, Griswold MG, Abate KH, Abbafati C, Kangevari MA, Kangevari ZA, Abdoli A, Benseñor IJM, Brunoni AR. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 [Internet]. Lancet. 2022 ; 400( 10347): 185-235.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00847-9
  • Fonte: Lancet. Unidade: FM

    Assuntos: CO-TERAPIA, GONADOTROFINAS, ENDOMETRIOSE, PLACEBOS

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIUDICE, Linda C et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet, v. 399, n. 10343, p. 2267-2279, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00622-5. Acesso em: 31 ago. 2024.
    • APA

      Giudice, L. C., As-sanie, S., Ferreira, J. C. A., Becker, C. M., Abrão, M. S., Lessey, B. A., et al. (2022). Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet, 399( 10343), 2267-2279. doi:10.1016/S0140-6736(22)00622-5
    • NLM

      Giudice LC, As-sanie S, Ferreira JCA, Becker CM, Abrão MS, Lessey BA, Brown E, Dynowski K, Wilk K, Li Y. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) [Internet]. Lancet. 2022 ; 399( 10343): 2267-2279.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00622-5
    • Vancouver

      Giudice LC, As-sanie S, Ferreira JCA, Becker CM, Abrão MS, Lessey BA, Brown E, Dynowski K, Wilk K, Li Y. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) [Internet]. Lancet. 2022 ; 399( 10343): 2267-2279.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00622-5
  • Fonte: Lancet. Unidade: IP

    Assuntos: CENTROS DE REABILITAÇÃO, REABILITAÇÃO DA DROGA, DEPENDENTES QUÍMICOS, DIREITOS HUMANOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      End compulsory drug treatment in the Asia-Pacific region. Lancet, v. 29 jan.-4 fe 2022, n. 10323, p. 419-421, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00003-4. Acesso em: 31 ago. 2024.
    • APA

      End compulsory drug treatment in the Asia-Pacific region. (2022). End compulsory drug treatment in the Asia-Pacific region. Lancet, 29 jan.-4 fe 2022( 10323), 419-421. doi:10.1016/S0140-6736(22)00003-4
    • NLM

      End compulsory drug treatment in the Asia-Pacific region [Internet]. Lancet. 2022 ; 29 jan.-4 fe 2022( 10323): 419-421.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00003-4
    • Vancouver

      End compulsory drug treatment in the Asia-Pacific region [Internet]. Lancet. 2022 ; 29 jan.-4 fe 2022( 10323): 419-421.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00003-4
  • Fonte: Lancet. Unidade: IP

    Assuntos: DESIGUALDADES SOCIAIS, DIREITOS HUMANOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      Archbishop Desmond Tutu and the universality of health and human rights. Lancet, v. 5-11 fe 2022, n. 10324, p. 503-504, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00121-0. Acesso em: 31 ago. 2024.
    • APA

      Archbishop Desmond Tutu and the universality of health and human rights. (2022). Archbishop Desmond Tutu and the universality of health and human rights. Lancet, 5-11 fe 2022( 10324), 503-504. doi:10.1016/S0140-6736(22)00121-0
    • NLM

      Archbishop Desmond Tutu and the universality of health and human rights [Internet]. Lancet. 2022 ; 5-11 fe 2022( 10324): 503-504.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00121-0
    • Vancouver

      Archbishop Desmond Tutu and the universality of health and human rights [Internet]. Lancet. 2022 ; 5-11 fe 2022( 10324): 503-504.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00121-0
  • Fonte: Lancet. Unidade: FFLCH

    Assunto: POLÍTICA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GÓMEZ, Eduardo J et al. Political science and global health policy. Lancet, v. 399, n. ju 2022, p. 2080-2082, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)00923-0. Acesso em: 31 ago. 2024.
    • APA

      Gómez, E. J., Singh, P., Shiffman, J., & Barberia, L. (2022). Political science and global health policy. Lancet, 399( ju 2022), 2080-2082. doi:10.1016/S0140-6736(22)00923-0
    • NLM

      Gómez EJ, Singh P, Shiffman J, Barberia L. Political science and global health policy [Internet]. Lancet. 2022 ; 399( ju 2022): 2080-2082.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00923-0
    • Vancouver

      Gómez EJ, Singh P, Shiffman J, Barberia L. Political science and global health policy [Internet]. Lancet. 2022 ; 399( ju 2022): 2080-2082.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1016/S0140-6736(22)00923-0

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024